Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| neutrophil | 3 studies | 29% ± 6% | |
| basal cell | 3 studies | 24% ± 9% |
Insufficient scRNA-seq data for expression of HCAR3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 75% | 168.61 | 431 / 578 | 56% | 2.94 | 650 / 1155 |
| bladder | 43% | 75.43 | 9 / 21 | 66% | 4.66 | 334 / 504 |
| spleen | 99% | 350.98 | 238 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 2233.47 | 881 / 929 | 0% | 0 | 0 / 0 |
| esophagus | 37% | 120.42 | 533 / 1445 | 57% | 3.38 | 105 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 13.80 | 41 / 45 |
| breast | 65% | 53.28 | 300 / 459 | 13% | 0.22 | 149 / 1118 |
| skin | 70% | 210.87 | 1267 / 1809 | 5% | 0.12 | 25 / 472 |
| uterus | 2% | 2.79 | 4 / 170 | 54% | 5.36 | 249 / 459 |
| adipose | 54% | 51.86 | 646 / 1204 | 0% | 0 | 0 / 0 |
| prostate | 26% | 26.40 | 64 / 245 | 9% | 0.19 | 46 / 502 |
| kidney | 24% | 15.72 | 21 / 89 | 8% | 0.36 | 68 / 901 |
| stomach | 3% | 3.03 | 12 / 359 | 27% | 1.40 | 77 / 286 |
| intestine | 2% | 2.22 | 24 / 966 | 26% | 1.05 | 137 / 527 |
| liver | 15% | 9.10 | 34 / 226 | 8% | 0.22 | 31 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.54 | 6 / 29 |
| pancreas | 0% | 0 | 0 / 328 | 17% | 1.27 | 30 / 178 |
| thymus | 4% | 2.34 | 26 / 653 | 9% | 0.40 | 53 / 605 |
| ovary | 0% | 0 | 0 / 180 | 4% | 0.09 | 18 / 430 |
| heart | 4% | 3.31 | 32 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 2.39 | 49 / 1335 | 0% | 0 | 0 / 0 |
| brain | 0% | 0.16 | 8 / 2642 | 2% | 0.03 | 13 / 705 |
| adrenal gland | 0% | 0 | 0 / 258 | 1% | 0.02 | 2 / 230 |
| muscle | 0% | 0.06 | 1 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0030054 | Cellular component | cell junction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0070553 | Molecular function | nicotinic acid receptor activity |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| Gene name | HCAR3 |
| Protein name | Hydroxycarboxylic acid receptor 3 (G-protein coupled receptor 109B) (G-protein coupled receptor HM74) (G-protein coupled receptor HM74B) (Niacin receptor 2) (Nicotinic acid receptor 2) Hydroxycarboxylic acid receptor 3 |
| Synonyms | HCA3 HM74B GPR109B NIACR2 |
| Description | FUNCTION: Receptor for 3-OH-octanoid acid mediates a negative feedback regulation of adipocyte lipolysis to counteract prolipolytic influences under conditions of physiological or pathological increases in beta-oxidation rates. Acts as a low affinity receptor for nicotinic acid. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. . |
| Accessions | ENST00000528880.3 P49019 A0A4Y1JWR6 |